McCormick's Confidence Gap: A Confident CEO, a Broken Tape, and the Themes It Stopped Saying

Q3 delivered +17% sales and margin expansion, but Americas volume keeps missing, a new packaging snag and cyclospora shock landed, and the reformulation story quietly vanished.

MKC · Earnings Call · 2026-10-01

A Confidence Gap the Tape Won't Let Slide

McCormick opened fiscal Q3 with the unmistakable voice of a company that believes it is winning: “Our third quarter demonstrates the resilience and differentiated performance of our flavor-centric business model in a dynamic environment.” — Brendan Foley, Chairman, President and CEO · 2026-10-01 On the surface the numbers cooperate — sales up 17% in constant currency, gross margin up 2.7pp to 40.2%, adjusted EPS of $0.86. But strip out the McCormick de Mexico acquisition and organic growth was just 2%. The gap between headline and underlying is the whole story. The market is not buying the confidence. MKC trades roughly 22% below its mid-August peak and around 58% below its 2020 high, and the multiple has compressed brutally: price to net income sits near 7.8x, down about 68% year over year. That is a stock priced for a serial disappointer, not for "differentiated performance." When management's tone and the tape diverge this sharply, the durable signal is usually the tape.

The Americas Fix That Keeps Slipping

The crux is Consumer Americas, and management finally conceded the timing. CEO Brendan Foley: “perhaps the implementation speed of everything that we're trying to do just wasn't as fast as we wanted it to as we're trying to coordinate plans with retailers.” — Brendan Foley, Chairman, President and CEO · 2026-10-01 This is a rare admission, and it rhymes with a pattern. On the prior call he insisted the company was running the same plan that worked before — “Our approach is broadly very similar to what we did over the last two to three years.” — Brendan Foley, Chairman, President, and CEO · 2026-06-25 But that playbook is now two calls deep without the payoff it delivered last time. Analysts pressed the point directly, asking whether retailer reluctance or the distraction of the massive Unilever integration were to blame; management rejected both, pinning it on coordination timing. The recipe-mix weakness got a sharper, more company-unique explanation this quarter: a "demand shift in store shelf location." Growth is concentrating in the Mexican aisle, while the bulk of McCormick's recipe-mix presence sits in a different aisle that is simply growing more slowly. That is a structural merchandising problem, not a macro one, and it explains why the fix has been stubborn. The current theme list bears this out — attention has migrated toward areas like cooking blends and toward assortment optimization as the levers management now leans on.

New Shocks — and the Silences That Matter

Two items are genuinely new this quarter. The first is a packaging supply constraint in Consumer Americas — vague by design, but material. Management flagged up to a one-point hit to Q4 total-company volume. Foley's framing is careful about what it is not:

The issue affects a specific packaging component. It really mostly just affects us in Consumer Americas. There's no Flavor Solutions exposure to this, and it's not a commodity availability or a raw material issue... it's really a packaging component and more of a conversion issue rather than the availability of material.
Brendan Foley, Chairman, President and CEO · 2026-10-01

The precision here is telling: management wants investors to know this is not a re-run of the 2021-22 supply-chain squeeze, just as they pre-emptively defended against COVID-era comparisons under analyst questioning. Whether that reassurance holds is exactly what the next call will test. The second new item is the cyclospora outbreak, which pressured U.S. QSR traffic and, crucially, cracked the market-wide top keywords this quarter — a genuinely company-linked shock that reached broad salience. It stacks on top of softer QSR customer demand in EMEA, where U.K. foot traffic weakened. Now the silences. Two of the loudest themes from just last quarter have gone quiet. Reformulation — which management had spent multiple calls hyping as an accelerating driver with large CPG customers — does not appear in this quarter's top themes. On the June call Foley had said “we're definitely seeing an acceleration in reformulation activity. And so those are areas that are on top of what would be a normal level of innovation activity.” — Brendan M. Foley, Chairman, President and CEO · 2025-06-26 That enthusiasm has faded from the script. Meanwhile tariff refund, the company's #1 keyword a quarter ago, is gone — even as tariff refunds dominate the broader market's keyword board. McCormick is de-risking itself from a theme the rest of the tape is still trading.

The Unilever Overhang Over a Cash Machine

The looming combination with Unilever Foods remains the swing factor. Management says integration planning is on schedule, with TSAs scoped for roughly two years and a phased exit, and it is validating the synergy case. The financial scaffolding is where investors will focus: effective net cash of roughly negative $4.6B against a stated leverage ratio near 2.9x. The deal math depends on delevering from 4x at close to 3x within two years. The engine to do that looks intact. Free cash flow (less stock comp) hit $328M, up dramatically year over year on higher profitability and improved working capital. Foley's cost discipline shows in the CCI program, which CFO Marcos Gabriel credited for holding margins together against a harsher environment and for giving him confidence “I do feel more confident today going into 2027 than back in 2019.” — Marcos Gabriel, CFO · 2026-10-01 That reassurance is doing real work, because it contradicts the hard numbers elsewhere. Operating margin slipped to 14.3%, and management raised its full-year cost-inflation guide to 6-7% from a prior mid-single-digit range. They are absorbing more inflation, not less, while telling investors the resilience is stronger than ever. The read: This was a quarter defined less by what it reported than by what it revealed about timing and tone. The headline growth was borrowed from an acquisition; the organic story is still a slow, halting repair in the Americas; and two prior talking points — reformulation and tariff refunds — were quietly retired just as a fresh packaging snag and a public-health shock arrived. The bull case rests almost entirely on the Unilever transaction and the cash generation funding it. Until Americas volume actually inflects, the confident words and the collapsing multiple will keep pointing in opposite directions.